BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung cancer
,
Intestine
,
Hematopoietic cell
,
Doxorubicin
,
rs7903146
,
CYP51
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
DCLK1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Occipital lobe
Parietal lobe
Cerebral cortex
Frontal lobe
Frontal cortex
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Duchenne muscular dystrophy
Huntington's disease
Muscular dystrophy
Immunoglobulin G4 deficiency
Ischemia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Versicans
Endothelin-1
Botulinum Toxins, Type A
Amphotericin B
((1S,2S,4R)-4-(4-((1S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulphamate
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR222
KDM1B
SUPT4H1
POU1F1
LAMA2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.
Doublecortin and CaM kinase-like-1 expression in pathological stage I non-small cell lung cancer.
Functional assessment of miR‑1291 in colon cancer cells.
APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases.
Spatial and temporal diversity of DCLK1 isoforms in developing mouse brain.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
DCLK1 as a Marker/Indicator of Stem Cell Response in Barrett's Esophagus/Esophageal Adenocarcinoma
Functional Dyspepsia Microbiome Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ